ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,483, issued on March 3, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Oxopyrrolidine urea FPR2 agonists" was invented by Pravin Sudhakar Shirude (Bangalore, India), Chandrasekhar Reddy Rachamreddy (Kadapa District, India), Vishweshwaraiah Baligar (Bangalore, India), Balaji Seshadri (Bangalore, India), Sudhakara Reddy Madduri (Bangalore, India), Ellen K. Kick (Pennington, N.J.) and Nicholas R. Wurtz (Pennington, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compounds of Formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also p...